CID 53492727
Linerixibat
Structural Information
- Molecular Formula
- C28H38N2O7S
- SMILES
- CCCC[C@@]1(CS(=O)(=O)C2=C(C=C(C(=C2)CNC(CC(=O)O)CC(=O)O)OC)[C@H](N1)C3=CC=CC=C3)CC
- InChI
- InChI=1S/C28H38N2O7S/c1-4-6-12-28(5-2)18-38(35,36)24-13-20(17-29-21(14-25(31)32)15-26(33)34)23(37-3)16-22(24)27(30-28)19-10-8-7-9-11-19/h7-11,13,16,21,27,29-30H,4-6,12,14-15,17-18H2,1-3H3,(H,31,32)(H,33,34)/t27-,28-/m1/s1
- InChIKey
- CZGVOBIGEBDYTP-VSGBNLITSA-N
- Compound name
- 3-[[(3R,5R)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-4,5-dihydro-2H-1lambda6,4-benzothiazepin-8-yl]methylamino]pentanedioic acid
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 547.24728 | 220.8 |
[M+Na]+ | 569.22922 | 225.7 |
[M+NH4]+ | 564.27382 | 224.5 |
[M+K]+ | 585.20316 | 218.4 |
[M-H]- | 545.23272 | 219.7 |
[M+Na-2H]- | 567.21467 | 224.1 |
[M]+ | 546.23945 | 221.4 |
[M]- | 546.24055 | 221.4 |